- Tytuł:
- Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.
- Autorzy:
- Źródło:
- Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 May 30; Vol. 42 (1), pp. 135. Date of Electronic Publication: 2023 May 30.
- Typ publikacji:
- Published Erratum